Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01010139 · ClinicalTrials.gov registry record · NA
Pharmacokinetic and Comparative Bioavailability Study of Codeine Sulfate Under Fasted Conditions
A NA study, sponsored by Roxane Laboratories.
- Completed
- Registry status
- NA
- Development phase
- 18
- Enrollment target
NCT01010139 is a NA study that has completed, run by Roxane Laboratories. The registered enrollment target is 18 participants.
The verdict
NCT01010139, a NA study, has completed, sponsored by Roxane Laboratories.
- COMPLETED
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
Study Summary
The objective of this study designed to characterize the pharmacokinetics and comparative bioavailability of Roxane Laboratories' codeine sulfate tablets after oral administration of 60 mg doses as 1 x 60 mg, 2 x 30 mg and 4 x 15 mg under fasted conditions.
Interventions
- DRUG Codeine Sulfate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2006-08 |
| Est. Completion | 2006-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01010139
The ClinicalTrials.gov registry entry for NCT01010139 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Roxane Laboratories, which has 93 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Codeine Sulfate is the first listed.
NCT01010139 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01010139 about?
NCT01010139 is a clinical study titled "Pharmacokinetic and Comparative Bioavailability Study of Codeine Sulfate Under Fasted Conditions". The objective of this study designed to characterize the pharmacokinetics and comparative bioavailability of Roxane Laboratories' codeine sulfate tablets after oral administration of 60 mg doses as 1 x 60 mg, 2 x 30 mg and 4 x 15 mg under fasted conditions.
What is the current status of trial NCT01010139?
This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2006-08. Estimated completion is 2006-09.
What interventions are being tested in trial NCT01010139?
The interventions under investigation include: Codeine Sulfate (DRUG).
Who is sponsoring clinical trial NCT01010139?
This trial is sponsored by Roxane Laboratories, which has 93 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.